These final results, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the notion of targeting ACKR3 as a novel technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant Ailments. January three, 2024 Donating https://stephenn670rmc8.wikinewspaper.com/user